Alain Dancour
Alain Dancour publishes mostly in Oncology, Surgery and Epidemiology, on topics such as Pancreatic and Hepatic Oncology Research, Neuroendocrine Tumor Research Advances and Hepatocellular Carcinoma Treatment and Prognosis.
- World rank
- #2,432,496 of 7,710,434 ranked researchers
- Rank in Israel
- #15,952 of 38,292
- Works
- 25
- Citations
- 1.1k
- Citations per work
- 45.9
What does Alain Dancour research?
Alain Dancour's work is mostly in Medicine (85%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2184.7%
- Medicine2184.7%
- Everything else415.3%
- 1Oncology28% of their works
- 2Surgery22% of their works
- 3Epidemiology15% of their works
- 4Hepatology8% of their works
- 5Pulmonary and Respiratory Medicine7% of their works
- 6Neurology4% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Neuroendocrine Tumor Research Advances
- Hepatocellular Carcinoma Treatment and Prognosis
- Pancreatitis Pathology and Treatment
- Neuroblastoma Research and Treatments
- Gallbladder and Bile Duct Disorders
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastrointestinal Tumor Research and Treatment
Which keywords describe Alain Dancour's research?
The keywords of their largest research topics: Immunotherapy, Pancreatic Cancer, Surgical Complications, Genetic Mutations, Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors, Epidemiology and Cholangiocarcinoma.
- Sunitinib
- Neuroblastoma
- ERCP
- Biliary Tract Cancer
- Chronic Pancreatitis
- Surgical Management
- Liver Cancer
- Cholangiocarcinoma
- Pancreatic Neuroendocrine Tumors
- Genetic Mutations
- Pancreatic Cancer
- Immunotherapy
- Surgical Complications
- Neuroendocrine Tumors
- Epidemiology
- Hepatocellular Carcinoma
- Prognostic Factors
- Acute Pancreatitis
- ALK
- Cholecystitis
- Intrahepatic Cholangiocarcinoma
- Imatinib Mesylate
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Immunotherapy212 topics
- Pancreatic Cancer181 topic
- Surgical Complications181 topic
- Genetic Mutations142 topics
- Neuroendocrine Tumors111 topic
- Pancreatic Neuroendocrine Tumors111 topic
- Epidemiology72 topics
- Cholangiocarcinoma62 topics
- Hepatocellular Carcinoma61 topic
- Liver Cancer61 topic
- Prognostic Factors52 topics
- Surgical Management52 topics
- Acute Pancreatitis41 topic
- Chronic Pancreatitis41 topic
- ALK31 topic
- Biliary Tract Cancer31 topic
- Cholecystitis31 topic
- ERCP31 topic
- Intrahepatic Cholangiocarcinoma31 topic
- Neuroblastoma31 topic
- Imatinib Mesylate21 topic
- Sunitinib21 topic
Where does Alain Dancour work?
Alain Dancour's main affiliation in the publication record is Shaare Zedek Medical Center, Israel.
How many publications and citations does Alain Dancour have?
OpenAlex counts 25 works and 1,148 citations for Alain Dancour, an h-index of 7, ranking #2,432,496 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alain Dancour. Posts are plain text and can be reported.